Yong Li

发表

Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial.

B. Monk, D. Matei, A. Oza, 2019, The Lancet. Oncology.

Efficacy of niraparib by time of surgery and postoperative residual disease status: A post hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study

Richard G. Moore, B. Monk, Aalok Kumar, 2022, Gynecologic oncology.

A genotype signature for predicting pathologic complete response in locally advanced rectal cancer.

Yingsong Wu, Hui-zhong Zhang, X. Wan, 2021, International journal of radiation oncology, biology, physics.

PD-1 Inhibitors Plus Capecitabine as Maintenance Therapy for Advanced Intrahepatic Cholangiocarcinoma: A Case Report and Review of Literature

Weiping Zhou, T. Zeng, Yong Li, 2021, Frontiers in Immunology.

Efficacy and Safety of Neoadjuvant Monoimmunotherapy With PD-1 Inhibitor for dMMR/MSI⁃H Locally Advanced Colorectal Cancer: A Single-Center Real-World Study

Chao Dong, Tao Wu, Yong Li, 2022, Frontiers in Immunology.

A multicentre single arm phase 2 trial of neoadjuvant pyrotinib and letrozole plus dalpiciclib for triple-positive breast cancer

Xinyu Zheng, G. Jerusalem, Tong Liu, 2022, Nature Communications.

QUADRA: A phase 2, open-label, single-arm study to evaluate niraparib in patients (pts) with relapsed ovarian cancer (ROC) who have received ≥3 prior chemotherapy regimens.

B. Monk, A. Oza, J. Berek, 2018 .

Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.

B. Monk, K. Jardon, I. Vergote, 2019, The New England journal of medicine.

Ad hoc Analysis of the Phase III ENGOT-OV16/NOVA Study: Niraparib Efficacy in Germline BRCA Wild-type Recurrent Ovarian Cancer with Homologous Recombination Repair Defects

A. Oza, J. Berek, G. Lindahl, 2022, Cancer research communications.

Perioperative chemotherapy of oxaliplatin combined with S-1 (SOX) versus postoperative chemotherapy of SOX or oxaliplatin with capecitabine (XELOX) in locally advanced gastric adenocarcinoma with D2 gastrectomy: A randomized phase III trial (RESOLVE trial)

Z. Li, Z. Zhou, Guoxin Li, 2019, Annals of Oncology.

Development of taxane-containing chemotherapy of doxorubicin-resistant diffuse large B-cell lymphoma

Jishi Wang, Hang Li, Yong Li, 2014, Anti-cancer drugs.

Prospective evaluation of the tolerability and efficacy of niraparib dosing based on baseline body weight and platelet count: Results from the PRIMA/ENGOT‐OV26/GOG‐3012 trial

B. Monk, P. Follana, M. Mirza, 2023, Cancer.